NOTCH3 drives fatty acid oxidation and ferroptosis resistance in aggressive meningiomas
- PMID: 40924320
- DOI: 10.1007/s11060-025-05208-5
NOTCH3 drives fatty acid oxidation and ferroptosis resistance in aggressive meningiomas
Abstract
Purpose: NOTCH3 is increasingly implicated for its oncogenic role in many malignancies, including meningiomas. While prior work has linked NOTCH3 expression to higher-grade meningiomas and treatment resistance, the metabolic phenotype of NOTCH3 activation remains unexplored in meningioma.
Methods: We performed single-cell RNA sequencing on NOTCH3 + human meningioma cell lines. Using the CH157-MN meningioma cell model, we overexpressed NOTCH3 intracellular domain (ICD) and performed untargeted metabolomic, lipidomic, and bulk RNA sequencing analyses as well as functional metabolic assays.
Results: We show that NOTCH3 mediates a metabolic shift towards fatty acid oxidation (FAO), depleting lipid availability and conferring resistance to ferroptosis. Single-cell RNA sequencing revealed a correlation with CD36, a key fatty acid transporter. Furthermore, patient-derived primary meningioma lines stratified by NOTCH3 expression confirmed higher CD36 expression and increased maximal mitochondrial respiration in NOTCH3-high cells in the presence of palmitate, supporting enhanced FAO. NOTCH3 ICD overexpression (OE) exhibited depletion of fatty acid pools, alongside transcriptional upregulation of canonical FAO genes. Functional mitochondrial assays confirmed elevated oxidative respiration in the presence of palmitate compared with controls. Additionally, NOTCH3 OE cells exhibit increased resistance to RSL3-induced ferroptosis, a phenotype that was reversed with CPT1 inhibition.
Conclusion: These data establish a link between NOTCH3 signaling, lipid metabolic reprogramming, and ferroptosis evasion in aggressive meningioma cells. This metabolic shift may contribute to the malignant behavior observed in NOTCH3 + meningiomas, offering new insight into the biochemical vulnerabilities of these tumors.
Keywords: NOTCH3; Fatty acid oxidation; Ferroptosis; Meningioma metabolism; Tumor microenvironment.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests. Ethical approval: Human PDX samples were obtained under protocol #STU00095863 approved by the Northwestern Institutional Review Board (IRB).
Update of
-
NOTCH3 Drives Fatty Acid Oxidation and Ferroptosis Resistance in Aggressive Meningiomas.Res Sq [Preprint]. 2025 Jun 4:rs.3.rs-6779386. doi: 10.21203/rs.3.rs-6779386/v1. Res Sq. 2025. Update in: J Neurooncol. 2025 Sep 9. doi: 10.1007/s11060-025-05208-5. PMID: 40502769 Free PMC article. Updated. Preprint.
References
-
- Anastasi E, Campese AF, Bellavia D, Bulotta A, Balestri A, Pascucci M et al (2003) Expression of activated Notch3 in Transgenic mice enhances generation of T regulatory cells and protects against experimental autoimmune diabetes. J Immunol 171(9):4504–4511. https://doi.org/10.4049/jimmunol.171.9.4504 PubMed PMID: 14568923 - DOI - PubMed
-
- Lardelli M, Dahlstrand J, Lendahl U (1994) The novel Notch homologue mouse Notch 3 lacks specific epidermal growth factor-repeats and is expressed in proliferating neuroepithelium. Mech Dev 46(2):123–136. https://doi.org/10.1016/0925-4773(94)90081-7 PubMed PMID: 7918097 - DOI - PubMed
-
- Hamada Y, Kadokawa Y, Okabe M, Ikawa M, Coleman JR, Tsujimoto Y (1999) Mutation in Ankyrin repeats of the mouse Notch2 gene induces early embryonic lethality. Development 126(15):3415–3424. https://doi.org/10.1242/dev.126.15.3415 PubMed PMID: 10393120 - DOI - PubMed
-
- Krebs LT, Xue Y, Norton CR, Sundberg JP, Beatus P, Lendahl U et al (2003) Characterization of Notch3-deficient mice: normal embryonic development and absence of genetic interactions with a Notch1 mutation. Genesis 37(3):139–143. https://doi.org/10.1002/gene.10241 PubMed PMID: 14595837 - DOI - PubMed